These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8615889

  • 1. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes.
    Silva CL, Cruz HN, Violante FA, Cordeiro RS, Martins MA, Noël F.
    Biochem Pharmacol; 1996 Jan 26; 51(2):193-6. PubMed ID: 8615889
    [Abstract] [Full Text] [Related]

  • 2. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M.
    Pharmacology; 1997 May 26; 54(5):261-70. PubMed ID: 9380772
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S, Mikashima H, Muramoto Y, Terasawa M, Setoguchi M, Tahara T.
    Prostaglandins; 1990 Dec 26; 40(6):571-83. PubMed ID: 1965554
    [Abstract] [Full Text] [Related]

  • 4. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
    Domingo MT, Piro F, Broquet C, Auclair E, Chabrier PE, Braquet P.
    Lipids; 1992 Aug 26; 27(8):582-6. PubMed ID: 1328798
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ, O'Neill C.
    Lipids; 1991 Dec 26; 26(12):1189-92. PubMed ID: 1668116
    [Abstract] [Full Text] [Related]

  • 6. Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI).
    Fujita M, Seki T, Inada H, Shimizu K, Takahama A, Sano T.
    Bioorg Med Chem Lett; 2002 Mar 11; 12(5):771-4. PubMed ID: 11858999
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct 11; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 8. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H, Imanishi N, Natsume Y, Morooka S.
    Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770
    [Abstract] [Full Text] [Related]

  • 9. The benzodiazepine receptor ligands RO 5-4864 and RO 15-1788 do not block the inhibition of PAF-induced platelet aggregation seen with the hetrazepine WEB2086.
    Griffin K, Hong T, Levy JV.
    Biochem Biophys Res Commun; 1989 Apr 14; 160(1):263-7. PubMed ID: 2540748
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K.
    Arzneimittelforschung; 1990 Nov 14; 40(11):1201-5. PubMed ID: 2085331
    [Abstract] [Full Text] [Related]

  • 11. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP, Moreno A, Ruiz-Ruiz MI, García-Campos J, Sánchez de la Cuesta F.
    Eur J Pharmacol; 1998 Oct 30; 360(1):37-42. PubMed ID: 9845270
    [Abstract] [Full Text] [Related]

  • 12. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M.
    Am J Physiol; 1998 Jan 30; 274(1):C47-57. PubMed ID: 9458712
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE.
    J Lipid Mediat; 1993 Aug 30; 8(1):31-51. PubMed ID: 8257776
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec 30; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB, Herion F, Raskinet R, David JL, Gustin P, Dessy C, Lekeux P.
    Zentralbl Veterinarmed A; 1996 Sep 30; 43(7):399-413. PubMed ID: 8921726
    [Abstract] [Full Text] [Related]

  • 16. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series.
    Weber KH, Heuer H.
    Int Arch Allergy Appl Immunol; 1989 Sep 30; 88(1-2):82-7. PubMed ID: 2540098
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M.
    J Pharmacol Exp Ther; 1991 Oct 30; 259(1):78-85. PubMed ID: 1656030
    [Abstract] [Full Text] [Related]

  • 18. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R, Hirafuji M, Keraly CL, Delautier D, Bidault J, Benveniste J.
    Br J Pharmacol; 1989 Oct 30; 98(2):653-61. PubMed ID: 2555017
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
    Komatsu H, Amano M.
    Int J Immunopharmacol; 1997 Oct 30; 19(11-12):661-7. PubMed ID: 9669206
    [Abstract] [Full Text] [Related]

  • 20. The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes.
    Svetlov SI, Barton JM, Olson MS.
    Life Sci; 1996 Oct 30; 58(5):PL 81-6. PubMed ID: 8594301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.